Hans Van Eenennaam
Oss, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Zigakibart Potently Inhibits A Proliferation-Inducing Ligand-Mediated IgA Production, Addressing IgAN Pathogenesis Root Causes.
Journal: Kidney international reports
Published: November 28, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy.
Journal: Kidney international
Published: March 14, 2025
Epitope mapping of monoclonal antibodies: a comprehensive comparison of different technologies.
Journal: mAbs
Published: November 27, 2023
CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.
Journal: Cellular & molecular immunology
Published: July 11, 2023
Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET.
Journal: EJNMMI research
Published: May 11, 2023
Development of 89Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration.
Journal: Journal for immunotherapy of cancer
Published: September 22, 2022
Integrated Single-Cell (Phospho-)Protein and RNA Detection Uncovers Phenotypic Characteristics and Active Signal Transduction of Human Antibody-Secreting Cells.
Journal: Molecular & cellular proteomics : MCP
Published: August 24, 2022
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: August 23, 2022
CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment.
Journal: Nature communications
Published: May 26, 2022
Single-cell intracellular epitope and transcript detection reveals signal transduction dynamics.
Journal: Cell reports methods
Published: January 20, 2021
Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion.
Journal: Frontiers in immunology
Published: August 07, 2020
Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab.
Journal: Molecular cancer therapeutics
Published: August 15, 2019
Last Updated: 09/26/2026